G0476 Insurance Policy Changes

HCPCS G0476 is officially defined as "Infectious agent detection by nucleic acid (dna or rna); human papillomavirus (hpv), high-risk types (e.g., 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 68) for cervical cancer screening, must be performed in addition to pap test." HCPCS G0476 is referenced in 4 tracked payer policy changes from Medicare/CMS and EmblemHealth. For billers and coders, staying current on payer-specific coverage criteria, reimbursement rules, and prior-authorization requirements for HCPCS G0476 is critical to clean claim submission. Each entry below links to the full policy analysis with effective dates and action steps.